Effects of the GABA B receptor-positive modulators CGP7930 and rac-BHFF in baclofen- and γ-hydroxybutyrate-discriminating pigeons

Journal of Pharmacology and Experimental Therapeutics

Volumn 341, Issue 2, 2012, Pages 369-376

  Koek, Wouter ^a   France, Charles P ^a   Cheng, Kejun ^b   Rice, Kenner C ^b  

^a UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^b NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2,6 DI TERT BUTYL 4 (3 HYDROXY 2,2 DIMETHYLPROPYL)PHENOL; 3 AMINOPROPYL(DIETHOXYMETHYL)PHOSPHINIC ACID; 4 AMINOBUTYRIC ACID B RECEPTOR; 4 AMINOBUTYRIC ACID RECEPTOR STIMULATING AGENT; 4 HYDROXYBUTYRIC ACID; 5,7 DI TERT BUTYL 3 HYDROXY 3 TRIFLUOROMETHYL 3H BENZOFURAN 2 ONE; BACLOFEN; DIAZEPAM; MORPHINE; UNCLASSIFIED DRUG; (R,S) 5,7 DI TERT BUTYL 3 HYDROXY 3 TRIFLUOROMETHYL 3H BENZOFURAN 2 ONE; (R,S)-5,7-DI-TERT-BUTYL-3-HYDROXY-3-TRIFLUOROMETHYL-3H-BENZOFURAN-2-ONE; 4 AMINOBUTYRIC ACID B RECEPTOR STIMULATING AGENT; 4 AMINOBUTYRIC ACID RECEPTOR BLOCKING AGENT; BENZOFURAN DERIVATIVE; OXYBATE SODIUM; PHENOL DERIVATIVE; PHOSPHINIC ACID DERIVATIVE;

ANIMAL EXPERIMENT; ARTICLE; COLUMBIA LIVIA; CONTROLLED STUDY; DOSE RESPONSE; DRUG DOSE INCREASE; DRUG EFFECT; DRUG EFFICACY; DRUG MECHANISM; DRUG POTENCY; DRUG POTENTIATION; DRUG TOLERABILITY; IN VIVO STUDY; NONHUMAN; PIGEON; PRIORITY JOURNAL; SUBSTITUTION REACTION; ANIMAL; INSTRUMENTAL CONDITIONING; METABOLISM; PERCEPTIVE DISCRIMINATION; PIGEONS AND DOVES;

ANIMALS; BACLOFEN; BENZOFURANS; COLUMBIDAE; CONDITIONING, OPERANT; DISCRIMINATION (PSYCHOLOGY); GABA ANTAGONISTS; GABA-B RECEPTOR AGONISTS; PHENOLS; PHOSPHINIC ACIDS; RECEPTORS, GABA-B; SODIUM OXYBATE;

EID: 84859952070     PISSN: 00223565     EISSN: 15210103     Source Type: Journal    
DOI: 10.1124/jpet.111.190975     Document Type: Article

References (47)

1. Adams CL and Lawrence AJ (2007) CGP7930: a positive allosteric modulator of the GABAB receptor. CNS Drug Rev 13:308-316. (Pubitemid 47481089)
2. B receptor system in alcoholism and stress: focus on clinical studies and treatment perspectives. Alcohol 43:559-563.
3. B receptor. J Biol Chem 279:29085-29091.
4. Carai MA, Colombo G, Froestl W, and Gessa GL (2004) In vivo effectiveness of CGP7930, a positive allosteric modulator of the GABAB receptor. Eur J Pharmacol 504:213-216. (Pubitemid 39488217)
5. B agonists are differentially attenuated by CGP35348. Eur J Pharmacol 538:85-93.
6. Carter LP, Flores LR, Wu H, Chen W, Unzeitig AW, Coop A, and France CP (2003) The role of GABAB receptors in the discriminative stimulus effects of γ-hydroxybutyrate in rats: time course and antagonism studies. J Pharmacol Exp Ther 305:668-674. (Pubitemid 36459185)
7. Carter LP, Koek W, and France CP (2009) Behavioral analyses of GHB: receptor mechanisms. Pharmacol Ther 121:100-114.
8. Carter LP, Unzeitig AW, Wu H, Chen W, Coop A, Koek W, and France CP (2004) The discriminative stimulus effects of γ-hydroxybutyrate and related compounds in rats discriminating baclofen or diazepam: the role of GABAB and GABAA receptors. J Pharmacol Exp Ther 309:540-547. (Pubitemid 38542605)
9. Castelli MP, Casu A, Casti P, Lobina C, Carai MA, Colombo G, Solinas M, Giunta D, Mugnaini C, Pasquini S, et al. (2012) Characterization of COR627 and COR628, two novel positive allosteric modulators of the GABAB receptor. J Pharmacol Exp Ther 340:529-538.
10. Chen Y, Menendez-Roche N, and Sher E (2006) Differential modulation by the GABAB receptor allosteric potentiator 2,6-di-tert-butyl-4-(3-hydroxy-2,2- dimethylpropyl)-phenol (CGP7930) of synaptic transmission in the rat hippocampal CA1 area. J Pharmacol Exp Ther 317:1170-1177. (Pubitemid 43764122)
11. Colpaert FC (1999) Drug discrimination in neurobiology. Pharmacol Biochem Behav 64:337-345.
12. Cryan JF, Kelly PH, Chaperon F, Gentsch C, Mombereau C, Lingenhoehl K, Froestl W, Bettler B, Kaupmann K, and Spooren WP (2004) Behavioral characterization of the novel GABAB receptor-positive modulator GS39783 (N,N′-dicyclopentyl-2- methylsulfanyl-5-nitro-pyrimidine-4,6-diamine): anxiolytic-like activity without side effects associated with baclofen or benzodiazepines. J Pharmacol Exp Ther 310:952-963. (Pubitemid 39108915)
13. Dar MS (1996) Mouse cerebellar GABAB participation in the expression of acute ethanol-induced ataxia and in its modulation by the cerebellar adenosinergic A1 system. Brain Res Bull 41:53-59.
14. B receptor antagonist, agonists and allosteric positive modulator on the cocaine-induced self-administration and drug discrimination. Eur J Pharmacol 574:148-157.
15. Frankowska M, Filip M, and Przegaliński E (2007) Effects of GABAB receptor ligands in animal tests of depression and anxiety. Pharmacol Rep 59:645-655. (Pubitemid 351586555)
16. Guery S, Floersheim P, Kaupmann K, and Froestl W (2007) Syntheses and optimization of new GS39783 analogues as positive allosteric modulators of GABA B receptors. Bioorg Med Chem Lett 17:6206-6211. (Pubitemid 47552827)
17. Hensler JG, Advani T, Burke TF, Cheng K, Rice KC, and Koek W (2012) GABAB receptor-positive modulators: brain region-dependent effects. J Pharmacol Exp Ther 340:19-26.
18. Institute of Laboratory Animal Resources (1996) Guide for the Care and Use of Laboratory Animals 7th ed. Institute of Laboratory Animal Resources, Commission on Life Sciences, National Research Council, Washington DC.
19. Jacobson LH and Cryan JF (2008) Evaluation of the anxiolytic-like profile of the GABAB receptor positive modulator CGP7930 in rodents. Neuropharmacology 54:854-862.
20. Jensen AA and Spalding TA (2004) Allosteric modulation of G-protein coupled receptors. Eur J Pharm Sci 21:407-420. (Pubitemid 38283914)
21. Kenakin T (2009) A Pharmacology Primer: Theory, Application and Methods, 3rd ed. Academic, New York.
22. Kerr DI and Ong J (1995) GABAB receptors. Pharmacol Ther 67:187-246.
23. Koek W, Chen W, Mercer SL, Coop A, and France CP (2006) Discriminative stimulus effects of γ-hydroxybutyrate: role of training dose. J Pharmacol Exp Ther 317: 409-417.
24. Koek W, Flores LR, Carter LP, Lamb RJ, Chen W, Wu H, Coop A, and France CP (2004) Discriminative stimulus effects of γ-hydroxybutyrate in pigeons: role of diazepam-sensitive and -insensitive GABAA and GABAB receptors. J Pharmacol Exp Ther 308:904-911. (Pubitemid 38263964)
25. Koek W and France CP (2008) Cataleptic effects of γ-hydroxybutyrate (GHB) and baclofen in mice: mediation by GABAB receptors, but differential enhancement by N-methyl-D-aspartate (NMDA) receptor antagonists. Psychopharmacology 199: 191-198.
26. Koek W, France CP, Cheng K, and Rice KC (2010) GABAB receptor-positive modulators: enhancement of GABAB receptor agonist effects in vivo. J Pharmacol Exp Ther 335:163-171.
27. Koek W, Khanal M, and France CP (2007a) Synergistic interactions between 'club drugs': γ-hydroxybutyrate and phencyclidine enhance each other's discriminative stimulus effects. Behav Pharmacol 18:807-810. (Pubitemid 350076438)
28. Koek W, Mercer SL, and Coop A (2007b) Cataleptic effects of γ-hydroxybutyrate (GHB), its precursor γ-butyrolactone (GBL), and GABAB receptor agonists in mice: differential antagonism by the GABAB receptor antagonist CGP35348. Psychopharmacology 192:407-414. (Pubitemid 46701575)
29. B receptor antagonist 3-aminopropyl(diethoxymethyl) phosphinic acid (CGP35348). J Pharmacol Exp Ther 330:876-883.
30. Liang JH, Chen F, Krstew E, Cowen MS, Carroll FY, Crawford D, Beart PM, and Lawrence AJ (2006) The GABAB receptor allosteric modulator CGP7930, like baclofen, reduces operant self-administration of ethanol in alcohol-preferring rats. Neuropharmacology 50:632-639.
31. Maccioni P, Carai MA, Kaupmann K, Guery S, Froestl W, Leite-Morris KA, Gessa GL, and Colombo G (2009) Reduction of alcohol's reinforcing and motivational properties by the positive allosteric modulator of the GABAB receptor, BHF177, in alcohol-preferring rats. Alcohol Clin Exp Res 33:1749-1756.
32. Maccioni P, Fantini N, Froestl W, Carai MA, Gessa GL, and Colombo G (2008) Specific reduction of alcohol's motivational properties by the positive allosteric modulator of the GABAB receptor, GS39783-comparison with the effect of the GABAB receptor direct agonist, baclofen. Alcohol Clin Exp Res 32:1558-1564.
33. Malherbe P, Masciadri R, Norcross RD, Knoflach F, Kratzeisen C, Zenner MT, Kolb Y, Marcuz A, Huwyler J, Nakagawa T, et al. (2008) Characterization of (R,S)-5,7- di-tert-butyl-3-hydroxy-3-trifluoromethyl-3H-benzofuran-2-one as a positive allosteric modulator of GABAB receptors. Br J Pharmacol 154:797-811. (Pubitemid 351821586)
34. Markou A, Paterson NE, and Semenova S (2004) Role of γ-aminobutyric acid (GABA) and metabotropic glutamate receptors in nicotine reinforcement: potential pharmacotherapies for smoking cessation. Ann NY Acad Sci 1025:491-503. (Pubitemid 39643899)
35. Mathivet P, Bernasconi R, De Barry J, Marescaux C, and Bittiger H (1997) Binding characteristics of γa-hydroxybutyric acid as a weak but selective GABAB receptor agonist. Eur J Pharmacol 321:67-75. (Pubitemid 27096618)
36. 3H](2E)-(5- hydroxy-5,7,8,9-tetrahydro-6H-benzo[a][7]annulen-6- ylidene) ethanoic acid in the rat brain. J Pharmacol Exp Ther 299:1148-1153.
37. Mombereau C, Lhuillier L, Kaupmann K, and Cryan JF (2007) GABAB receptor-positive modulation-induced blockade of the rewarding properties of nicotine is associated with a reduction in nucleus accumbens DeltaFosB accumulation. J Pharmacol Exp Ther 321:172-177. (Pubitemid 46456987)
38. Orrù A, Lai P, Lobina C, Maccioni P, Piras P, Scanu L, Froestl W, Gessa GL, Carai MA, and Colombo G (2005) Reducing effect of the positive allosteric modulators of the GABAB receptor, CGP7930 and GS39783, on alcohol intake in alcohol-preferring rats. Eur J Pharmacol 525:105-111. (Pubitemid 41689029)
39. B autoreceptors. Clin Exp Pharmacol Physiol 35: 1113-1115.
40. B receptors decreased nicotine self-administration and counteracted nicotine-induced enhancement of brain reward function in rats. J Pharmacol Exp Ther 326:306-314.
41. Pierau FK, Yakimova KS, Sann H, and Schmid HA (1997) Specific action of GABAB ligands on the temperature sensitivity of hypothalamic neurons. Ann NY Acad Sci 813:146-155. (Pubitemid 27189884)
42. Pilc A and Nowak G (2005) GABAergic hypotheses of anxiety and depression: focus on GABA-B receptors. Drugs Today (Barc) 41:755-766. (Pubitemid 43074784)
43. Pin JP, Kniazeff J, Binet V, Liu J, Maurel D, Galvez T, Duthey B, Havlickova M, Blahos J, Prézeau L, et al. (2004) Activation mechanisms of the heterodimeric GABAB receptor. Biochem Pharmacol 68:1565-1572. (Pubitemid 39286461)
44. Snead OC 3rd (1977) γ-Hydroxybutyrate. Life Sci 20:1935-1943.
45. Urwyler S, Mosbacher J, Lingenhoehl K, Heid J, Hofstetter K, Froestl W, Bettler B, and Kaupmann K (2001) Positive allosteric modulation of native and recombinant γ-aminobutyric acidB receptors by 2,6-di-tert-butyl-4-(3- hydroxy-2,2-dimethylpropyl)- phenol (CGP7930) and its aldehyde analog CGP13501. Mol Pharmacol 60:963-971. (Pubitemid 33027431)
46. Urwyler S, Pozza MF, Lingenhoehl K, Mosbacher J, Lampert C, Froestl W, Koller M, and Kaupmann K (2003) N,N′-dicyclopentyl-2-methylsulfanyl-5- nitro-pyrimidine- 4,6-diamine (GS39783) and structurally related compounds: novel allosteric enhancers of γ-aminobutyric acid B receptor function. J Pharmacol Exp Ther 307: 322-330.
47. Vlachou S and Markou A (2010) GABAB receptors in reward processes. Adv Pharmacol 58:315-371.